JP2022552520A5 - - Google Patents
Info
- Publication number
- JP2022552520A5 JP2022552520A5 JP2022522022A JP2022522022A JP2022552520A5 JP 2022552520 A5 JP2022552520 A5 JP 2022552520A5 JP 2022522022 A JP2022522022 A JP 2022522022A JP 2022522022 A JP2022522022 A JP 2022522022A JP 2022552520 A5 JP2022552520 A5 JP 2022552520A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- disease
- cough
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19203174.8 | 2019-10-15 | ||
| EP19203174 | 2019-10-15 | ||
| PCT/EP2020/078856 WO2021074198A1 (en) | 2019-10-15 | 2020-10-14 | Novel tetrazoles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022552520A JP2022552520A (ja) | 2022-12-16 |
| JP2022552520A5 true JP2022552520A5 (enExample) | 2023-10-24 |
| JP7612682B2 JP7612682B2 (ja) | 2025-01-14 |
Family
ID=68289875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522022A Active JP7612682B2 (ja) | 2019-10-15 | 2020-10-14 | 新規なテトラゾール |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12497401B2 (enExample) |
| EP (1) | EP4045053B1 (enExample) |
| JP (1) | JP7612682B2 (enExample) |
| CN (1) | CN114555601B (enExample) |
| WO (1) | WO2021074198A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7612682B2 (ja) * | 2019-10-15 | 2025-01-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規なテトラゾール |
| JP7565457B2 (ja) | 2021-04-14 | 2024-10-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ＴＲＰＡ１阻害剤としての３Ｈ，４Ｈ－チエノ－［２，３－ｄ］ピリミジン－４－オン誘導体 |
| IT202100015098A1 (it) * | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
| WO2025167992A1 (zh) * | 2024-02-08 | 2025-08-14 | 宜昌人福药业有限责任公司 | 一种非选择性阳离子通道trpa1拮抗剂及其用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5982296A (en) | 1995-06-07 | 1996-12-30 | G.D. Searle & Co. | Method to treat cardiofibrosis with a combination of an angi otensin ii antagonist and spironolactone |
| US7754709B2 (en) | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| PE20120834A1 (es) | 2009-03-23 | 2012-07-25 | Glenmark Pharmaceuticals Sa | Derivados de furopirimidindiona como moduladores de trpa1 |
| KR101591153B1 (ko) | 2010-12-20 | 2016-02-02 | 그렌마크 파머수티칼스 에스. 아. | Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물 |
| RU2014100744A (ru) | 2011-06-13 | 2015-07-20 | Гленмарк Фармасьютикалс С.А. | Лечение респираторных нарушений с помощью trpa1 антагонистов |
| WO2015155306A1 (en) * | 2014-04-11 | 2015-10-15 | Almirall, S.A. | New trpa1 antagonists |
| EP3180345B1 (en) | 2014-08-11 | 2018-10-10 | Hydra Biosciences, Inc. | Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders |
| WO2016081649A1 (en) | 2014-11-18 | 2016-05-26 | Emory University | Thieno[2,3-d]pyrimidin-4-one derivatives as nmdar modulators and uses related thereto |
| WO2016133888A1 (en) | 2015-02-16 | 2016-08-25 | Biota Pharmaceuticals, Inc. | Compounds for treating respiratory syncytial virus infections |
| WO2017060488A1 (en) * | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
| WO2019015583A1 (en) | 2017-07-17 | 2019-01-24 | Nanjing Ruijie Pharmatech Co., Ltd. | NOVEL COMPOUNDS AND THEIR USES AS ACC INHIBITORS |
| PH12022550846A1 (en) | 2019-10-15 | 2023-03-27 | Boehringer Ingelheim Pharma | Thienopyrimidones as trpa1 inhibitors |
| JP7612682B2 (ja) * | 2019-10-15 | 2025-01-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規なテトラゾール |
| MX2022004565A (es) | 2019-10-15 | 2022-05-06 | Boehringer Ingelheim Int | Tienopirimidonas como inhibidores de trpa1. |
| KR20230087531A (ko) | 2020-10-14 | 2023-06-16 | 베링거 인겔하임 인터내셔날 게엠베하 | Trpa1 억제제로서 테트라졸 유도체 |
| IL301717B2 (en) | 2020-10-14 | 2026-05-01 | Boehringer Ingelheim Int | History of tetrazoles as TRPA1 inhibitors |
| JP7565457B2 (ja) | 2021-04-14 | 2024-10-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ＴＲＰＡ１阻害剤としての３Ｈ，４Ｈ－チエノ－［２，３－ｄ］ピリミジン－４－オン誘導体 |
-
2020
- 2020-10-14 JP JP2022522022A patent/JP7612682B2/ja active Active
- 2020-10-14 US US17/767,486 patent/US12497401B2/en active Active
- 2020-10-14 CN CN202080071658.5A patent/CN114555601B/zh active Active
- 2020-10-14 EP EP20793302.9A patent/EP4045053B1/en active Active
- 2020-10-14 WO PCT/EP2020/078856 patent/WO2021074198A1/en not_active Ceased